What is PCV Chemotherapy?

Chemotherapy administered as anti-cancer treatment is often done with combinations of drugs. This is known simply as combination chemotherapy. A number of years ago, doctors realized that chemotherapy was more effective against cancer if more than one such drug was administered to the patient, since different chemotherapy drugs tend to do different things in order to kill cancer cells, making the administration of three or four that much more effective in wiping out cancer cells than just one chemotherapy drug.

Acronyms in Chemotherapy

When combinations of chemotherapy drugs begin to be used frequently, doctors and researchers give them acronyms based—generally—on the first letter of the drug name (either the brand name of the drug of the chemical name of the drug). Therefore we have CHOP, ABVD, HyperCVAD, EPOCH, FOLFOX and other familiar combination chemotherapy regimens.

To that end, the combination chemotherapy regimen PCV is no different.

PCV Chemotherapy

PCV combination chemotherapy features the use of the following three chemotherapy drugs:

Historically, this combination chemotherapy regimen dates back to at least 1975 and a study that appeared in the journal Cancer. PCV has generally been used to fight specific types of brain tumors and similar cancers.

For this reason, PCV chemotherapy has a limited role in the treatment of lymphomas. Notably, it is sometimes given to patients who have a very difficult subtype of non-Hodgkin's lymphoma known as primary central nervous system lymphoma, or PCNSL. This is generally a very aggressive subtype of lymphoma with a poor prognosis for long-term survival. PCV chemotherapy has been used against primary CNS lymphoma often as a means of reducing symptoms in these patients but rarely is it regarded as a curative approach to this subtype.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap